Cutera, Inc. (NASDAQ:CUTR) EVP Ronald J. Santilli sold 1,068 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $33.20, for a total transaction of $35,457.60. Following the completion of the transaction, the executive vice president now directly owns 87,253 shares in the company, valued at $2,896,799.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Cutera, Inc. (NASDAQ CUTR) traded up 2.41% on Wednesday, reaching $34.00. 215,897 shares of the company’s stock traded hands. The company’s 50 day moving average is $27.89 and its 200-day moving average is $22.77. Cutera, Inc. has a 52-week low of $10.54 and a 52-week high of $34.91. The stock has a market cap of $476.17 million, a price-to-earnings ratio of 73.12 and a beta of 0.60.

Cutera (NASDAQ:CUTR) last released its earnings results on Monday, August 7th. The medical device company reported $0.13 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.03 by $0.10. The firm had revenue of $36.40 million for the quarter, compared to analysts’ expectations of $32.08 million. Cutera had a net margin of 5.35% and a return on equity of 13.05%. The company’s quarterly revenue was up 32.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.07 earnings per share. Equities analysts expect that Cutera, Inc. will post $0.52 EPS for the current year.

Cutera declared that its board has authorized a share buyback plan on Monday, August 7th that authorizes the company to repurchase $25.00 million in outstanding shares. This repurchase authorization authorizes the medical device company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: This news story was published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.watchlistnews.com/insider-selling-cutera-inc-cutr-evp-sells-1068-shares-of-stock/1496802.html.

Several research analysts have weighed in on CUTR shares. BidaskClub cut shares of Cutera from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Gabelli reissued a “buy” rating on shares of Cutera in a report on Wednesday, August 9th. Maxim Group reissued a “buy” rating and issued a $33.00 price target (up from $27.00) on shares of Cutera in a report on Thursday, July 13th. Zacks Investment Research raised shares of Cutera from a “sell” rating to a “buy” rating and set a $28.00 price target on the stock in a report on Tuesday, June 20th. Finally, Sidoti reissued a “buy” rating and issued a $32.00 price target (up from $30.00) on shares of Cutera in a report on Friday, July 7th. Six research analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and a consensus price target of $33.25.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC boosted its position in Cutera by 0.8% in the second quarter. Renaissance Technologies LLC now owns 1,214,500 shares of the medical device company’s stock worth $31,456,000 after buying an additional 9,100 shares during the last quarter. Gamco Investors INC. ET AL boosted its position in Cutera by 3.7% in the second quarter. Gamco Investors INC. ET AL now owns 576,363 shares of the medical device company’s stock worth $14,928,000 after buying an additional 20,363 shares during the last quarter. Vanguard Group Inc. boosted its position in Cutera by 3.4% in the second quarter. Vanguard Group Inc. now owns 570,948 shares of the medical device company’s stock worth $14,788,000 after buying an additional 18,549 shares during the last quarter. Kennedy Capital Management Inc. bought a new position in Cutera during the second quarter worth $9,426,000. Finally, Teton Advisors Inc. boosted its position in Cutera by 6.7% in the second quarter. Teton Advisors Inc. now owns 319,000 shares of the medical device company’s stock worth $8,262,000 after buying an additional 20,000 shares during the last quarter. Hedge funds and other institutional investors own 84.44% of the company’s stock.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.